London, UK — As much as 31% of the world’s population lives with metabolic syndrome, a cluster of health issues known to heighten the risk for serious conditions like type 2 diabetes, stroke, and heart disease. Now, compelling new research sheds light on an even more concerning link: metabolic syndrome may substantially increase an individual’s risk of developing Parkinson’s disease.
A recent study published in Neurology, the medical journal of the American Academy of Neurology, provides further evidence of a strong correlation between metabolic syndrome and Parkinson’s disease risk. Researchers found that people with metabolic syndrome were approximately 40% more likely to develop Parkinson’s disease than those without the condition.
What Exactly Is Metabolic Syndrome?
Metabolic syndrome isn’t a single illness but a combination of several health problems. For the purpose of this study, it was defined as having at least three of the following five conditions:
- Abdominal obesity: A waist circumference of 40 inches or more in men, or 35 inches or more in women.
- Elevated blood sugar levels: A fasting glucose of 100 milligrams per deciliter (mg/dL) or more.
- High blood pressure: A systolic blood pressure of 130 millimeters of mercury (mmHg) or more, or a diastolic blood pressure of 85 mmHg or more.
- Hypertriglyceridemia: High triglyceride levels of 150 mg/dL or more.
- Low HDL cholesterol levels: Less than 40 mg/dL in men or 50 mg/dL in women of “good cholesterol”.
The study, which analysed medical data from over 467,000 individuals in the U.K. Biobank over 15 years, revealed that 38% of participants had metabolic syndrome.
A Clear Signal: More Than Just a Heart Concern
Dr. Michael S. Okun, director of the Norman Fixel Institute for Neurological Diseases at UF Health, who was not involved in the study, highlighted that this research offers “one of the clearest signals yet that metabolic syndrome is more than just a cardiovascular concern — it may also prime the brain for Parkinson’s disease”. He further explained that these findings suggest abdominal obesity, high blood sugar, and abnormal cholesterol patterns are not just cardiovascular red flags, but may “accelerate brain neurodegeneration”.
What’s particularly striking is the “dose-response relationship,” as Dr. Okun pointed out. “In simple terms the more features of metabolic syndrome you have, the higher your Parkinson’s risk. Those folks carrying four or five components seem to be at the greatest risk”.
Weili Xu, PhD, professor of geriatric epidemiology at the Karolinska Institutet in Sweden and corresponding author of the study, also noted a higher risk for individuals with both metabolic syndrome and a genetic susceptibility for Parkinson’s disease. This suggests that “maintaining metabolic health may be especially important for people who have genes that increase their risk for Parkinson’s disease,” Xu added.
Prevention Is Possible: Taking Control of Your Metabolic Health
The good news is that metabolic syndrome is considered “highly modifiable”. Dr. Daniel Truong, a neurologist and medical director of the Truong Neuroscience Institute, commented that the study strengthens the argument that metabolic syndrome is a “broader systemic disorder with neurological consequences”.
He stressed the importance of early intervention, stating that Parkinson’s disease can “smolder for 10–20 years before motor symptoms appear”. Knowing that conditions like metabolic syndrome predispose individuals to Parkinson’s allows for much earlier identification and intervention, making prevention a real possibility.
Experts suggest that interventions targeting obesity, hypertension, and hyperglycemia may help delay or reduce risk in vulnerable populations. Dr. Truong advises motivating patients to lose weight and control hypertension to protect their brain, recommending closer attention to early Parkinsonian features in obese patients.
This research paves the way for a new frontier in Parkinson’s prevention, suggesting that managing waist circumference, blood pressure, glucose, and cholesterol could potentially delay or reduce the incidence of this neurodegenerative disorder. While further studies are needed to see if modifying these risk factors can change the outcome, the message is clear: prioritising your metabolic health could be a crucial step in protecting your brain’s future.